1. Home
  2. JVSA vs THTX Comparison

JVSA vs THTX Comparison

Compare JVSA & THTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JVSA
  • THTX
  • Stock Information
  • Founded
  • JVSA 2021
  • THTX 1993
  • Country
  • JVSA Hong Kong
  • THTX Canada
  • Employees
  • JVSA N/A
  • THTX N/A
  • Industry
  • JVSA
  • THTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • JVSA
  • THTX Health Care
  • Exchange
  • JVSA NYSE
  • THTX Nasdaq
  • Market Cap
  • JVSA 80.7M
  • THTX 93.3M
  • IPO Year
  • JVSA 2024
  • THTX N/A
  • Fundamental
  • Price
  • JVSA $10.68
  • THTX $1.85
  • Analyst Decision
  • JVSA
  • THTX Hold
  • Analyst Count
  • JVSA 0
  • THTX 1
  • Target Price
  • JVSA N/A
  • THTX N/A
  • AVG Volume (30 Days)
  • JVSA 30.9K
  • THTX 89.0K
  • Earning Date
  • JVSA 01-01-0001
  • THTX 04-09-2025
  • Dividend Yield
  • JVSA N/A
  • THTX N/A
  • EPS Growth
  • JVSA N/A
  • THTX N/A
  • EPS
  • JVSA 0.24
  • THTX N/A
  • Revenue
  • JVSA N/A
  • THTX $84,316,000.00
  • Revenue This Year
  • JVSA N/A
  • THTX $5.78
  • Revenue Next Year
  • JVSA N/A
  • THTX $2.47
  • P/E Ratio
  • JVSA $43.81
  • THTX N/A
  • Revenue Growth
  • JVSA N/A
  • THTX 5.75
  • 52 Week Low
  • JVSA $10.02
  • THTX $1.08
  • 52 Week High
  • JVSA $10.68
  • THTX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • JVSA N/A
  • THTX 58.80
  • Support Level
  • JVSA N/A
  • THTX $1.56
  • Resistance Level
  • JVSA N/A
  • THTX $2.06
  • Average True Range (ATR)
  • JVSA 0.00
  • THTX 0.14
  • MACD
  • JVSA 0.00
  • THTX 0.04
  • Stochastic Oscillator
  • JVSA 0.00
  • THTX 68.84

About JVSA JVSPAC ACQUISITION CORP

JVSPAC Acquisition Corp is blank check company.

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

Share on Social Networks: